公司概覽
業務類別 Medical Devices
業務概覽 Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
公司地址 100 Nagog Park, Acton, MA, USA, 01720
電話號碼 +1 978 600-7000
傳真號碼 --
公司網頁 https://www.insulet.com
員工數量 5400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Flavia H. Pease Executive Vice President, Chief Financial Officer -- 18/02/2026
Mr. Prem Singh Senior Vice President, Global Operations -- 29/04/2025
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer -- 18/02/2026
Mr. Dan Manea Senior Vice President and Chief Human Resources Officer -- 29/04/2025
Ms. Lauren D. Budden Group Vice President, Chief Accounting Officer and Controller 美元 407.00K 29/04/2025
Mr. Eric Benjamin Executive Vice President, Chief Product and Customer Experience Officer 美元 540.39K 29/04/2025
Mr. John W. Kapples Senior Vice President and General Counsel 美元 500.96K 29/04/2025
Mr. Amit Guliani Group Vice President, Software Engineering and Acting Chief Technology Officer -- 17/03/2025
Ms. Laetitia Cousin Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Timothy C. Stonesifer Independent Director 18/02/2026
Dr. Luciana Borio, M.D. Independent Director 18/02/2026
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer 18/02/2026
Dr. Wayne A.I. Frederick, M.D. Independent Director 18/02/2026
Dr. Jessica Hopfield, PhD Director 18/02/2026
Mr. Timothy John Scannell Chairman of the Board 18/02/2026
Mr. Michael R. Minogue Independent Director 18/02/2026
Ms. Elizabeth H. Weatherman Independent Director 18/02/2026
Mr. Robbie Huffines Director 18/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:56)
代號 名稱 佔比% 持有日期
ACWIiShares MSCI ACWI ETF0.03%28/02/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
FFSMFidelity Fundamental Small-Mid Cap ETF0.03%31/01/2026
IWViShares Russell 3000 ETF0.03%28/02/2026
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
ONEQFidelity Nasdaq Composite ETF0.02%27/02/2026
JMOMJPMorgan US Momentum Factor ETF0.02%27/02/2026
FTCFirst Trust Large Cap Gr AlphaDEX® ETF0.02%26/02/2026
FNDASchwab Fundamental U.S. Small CompanyETF0.02%28/02/2026
TMATMain Thematic Innovation ETF0.02%27/02/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
FXHFirst Trust Health Care AlphaDEX® ETF0.02%26/02/2026
GSEWGoldman Sachs Equal Wght US Lg Cp Eq ETF0.02%27/02/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.02%27/02/2026
EUSAiShares MSCI USA Equal Weighted ETF0.02%28/02/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
VONEVanguard Russell 1000 ETF0.02%31/01/2026
FTLSFirst Trust Long/Short Equity ETF0.02%26/02/2026
DSIiShares ESG MSCI KLD 400 ETF0.02%28/02/2026
XHEStt Strt® SPDR® S&P®HlthCrEqpmntETF0.01%27/02/2026
  1    2   3    4    5    6    7    8    9    10    11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.